Literature DB >> 30876620

Vaccination in Chronic Kidney Disease.

Snigdha Reddy1, Chandrika Chitturi2, Jerry Yee2.   

Abstract

Infections after cardiovascular disease are the second most common cause of death in the chronic kidney disease population. Vaccination is an important component of maintaining health and wellness in patients with kidney disease. There is a changing epidemiologic landscape for several vaccine-preventable illnesses from childhood to adulthood and unfounded public perception of safety concerns. Several mechanisms have been proposed to cause inadequate vaccine protection in this high-risk group with chronic kidney disease. These have led to recent advances in new designs for vaccination strategies in kidney disease. In this article, we discuss the current evidence and recommendations for vaccination in those with kidney disease and needing renal replacement therapy (dialysis and transplant).
Copyright © 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Immunizations; Vaccines

Mesh：

Substances：

Year:  2019        PMID： 30876620     DOI： 10.1053/j.ackd.2018.10.002

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN： 1548-5595            Impact factor:   3.620


  14 in total

1.  The DiaCoVAb Study in South Italy: Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients.

Authors:  Alessandra Fucci; Simona Giacobbe; Ilaria Guerriero; Yoko Suzumoto; Egildo Luca D'Andrea; Marianna Scrima; Maria Luisa Nolli; Anna Iervolino; Luigi Amedeo Chiuchiolo; Ermanno Salvatore; Roberta Renzulli; Ludovico La Peccerella; Giuseppe Marra; Marco Liuzzi; Domenico Santoro; Enrico Zulli; Romolo Gentile; Gennaro Clemente; Giovambattista Capasso
Journal:  Kidney Blood Press Res       Date:  2022-03-22       Impact factor: 3.096

2.  Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis.

Authors:  Kuei-Ting Tung; Yu-Sen Peng; Shih-Ping Hsu; Hon-Yen Wu; Yen-Ling Chiu; Ju-Yeh Yang; Mei-Fen Pai; Kai-Hsiang Shu; Szu-Yu Pan; Hui-Ming Lu; Wan-Yu Lin; Chun-Hsing Liao; Fang-Yeh Chu; Wan-Chuan Tsai
Journal:  Hemodial Int       Date:  2022-04-11       Impact factor: 1.543

3.  The impact of obesity on seasonal influenza: a single-center, retrospective study conducted in Israel.

Authors:  Alaa Atamna; Ron Daskal; Tanya Babich; Gida Ayada; Haim Ben-Zvi; Avishay Elis; Jihad Bishara; Tomer Avni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-02-11       Impact factor: 3.267

4.  Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients.

Authors:  Noa Berar Yanay; Sarit Freiman; Ma'anit Shapira; Samar Wishahi; Munir Hamze; Mohamad Elhaj; Maha Zaher; Zaher Armaly
Journal:  Kidney Int       Date:  2021-04-20       Impact factor: 10.612

5.  Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients.

Authors:  Giovanna Yazmin Arteaga-Müller; Mara Olivo-Gutierrez; Karla Lizbeth Favela-Aragon; Paola Alejandra Hernández-Castillo; Victor Esquivel-Gomez; Adrian Camacho-Ortiz
Journal:  Int Urol Nephrol       Date:  2021-04-23       Impact factor: 2.370

6.  Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.

Authors:  P Bouwmans; A L Messchendorp; J S Sanders; L Hilbrands; M E J Reinders; P Vart; F J Bemelman; A C Abrahams; M A van den Dorpel; M A Ten Dam; A P J de Vries; T Rispens; M Steenhuis; R T Gansevoort; M H Hemmelder
Journal:  BMC Nephrol       Date:  2022-02-05       Impact factor: 2.388

7.  Longevity of Humoral Response Six Months Following BNT162b2 Vaccine in Dialysis Patients.

Authors:  Timna Agur; Naomi Ben-Dor; Michal Herman-Edelstein; Tali Steinmetz; Shelly Lichtenberg; Shira Schneider; Dafna Yahav; Benaya Rozen-Zvi; Boris Zingerman
Journal:  Front Med (Lausanne)       Date:  2022-03-25

8.  The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Authors:  Jan-Stephan F Sanders; Frederike J Bemelman; A Lianne Messchendorp; Carla C Baan; Debbie van Baarle; Rob van Binnendijk; Dimitri A Diavatopoulos; Sophie C Frölke; Daryl Geers; Corine H GeurtsvanKessel; Gerco den Hartog; Marieke van der Heiden; Celine Imhof; Marcia M L Kho; Marion P G Koopmans; S Reshwan K Malahe; Wouter B Mattheussens; Renate van der Molen; Djenolan van Mourik; Ester B M Remmerswaal; Nynke Rots; Priya Vart; Rory D de Vries; Ron T Gansevoort; Luuk B Hilbrands; Marlies E J Reinders
Journal:  Transplantation       Date:  2022-04-01       Impact factor: 4.939

9.  Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study.

Authors:  Roberto Alcázar-Arroyo; José Portolés; Paula López-Sánchez; Felipe Zalamea; Karina Furaz; Ángel Méndez; Luis Nieto; Rosa Sánchez-Hernández; Soledad Pizarro; Alicia García; Mónica Pereira; Eduardo Gallego-Valcárcel; Rosario Llópez-Carratala; Ignacio Gadea-Gironés; Roberto Martín; Blanca Miranda
Journal:  Clin Kidney J       Date:  2021-03-09

10.  Short and mid-term SARS-CoV-2 antibody response after inactivated COVID-19 vaccine in hemodialysis and kidney transplant patients.

Authors:  Hamad Dheir; Aysel Tocoglu; Hande Toptan; Musa Pinar; Taner Demirci; Mehmet Koroglu; Selcuk Yaylaci; Ahmed Bilal Genc; Ahmed Cihad Genc; Necattin Firat; Oguz Karabay; Savas Sipahi
Journal:  J Med Virol       Date:  2022-03-22       Impact factor: 20.693
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.